Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports

(Reuters) -A consortium consisting of Warburg Pincus and KKR is in talks to acquire German packaging and medical equipment maker Gerresheimer AG (BS:GXId), Bloomberg News reported on Wednesday, citing people familiar with the matter.

The private equity firms have emerged as the frontrunner after they teamed up and other potential bidders including Bain Capital dropped out, Bloomberg News said.

Gerresheimer, which makes pens used to inject weight loss drugs such as Novo Nordisk (NYSE:NVO)’s Wegovy, has a market capitalization of about 2.74 billion euros ($2.99 billion), according to LSEG data.

Warburg Pincus, KKR and Gerresheimer declined to comment on the report.

In February, the company confirmed it was in early-stage discussions with private equity investors over a potential sale of the company.

Gerresheimer also halved its revenue guidance for 2025 over weakness in its cosmetics and food and beverage segments and now expects organic revenue growth in the range of 3% to 5% in 2025, down from the previous range of 7% to 10%.

($1 = 0.9173 euros)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.GXId: is this perennial leader facing new challenges?

With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is GXId one of them?

Unlock ProPicks AI to find out